ID
45568
Descrizione
Principal Investigator: Elaine Mardis, PhD, The Genome Institute, Washington University School of Medicine, St. Louis, MO, USA MeSH: Neoplasms https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000661 This study aims to elucidate the genetic determinants of susceptibility to aggressive prostate carcinoma. To this end, germ line whole exome sequence has been generated from patients with aggressive prostate cancer. Whole genome sequence for a representative subset of tumors from patients whose cancer was resistant to primary therapy is included as well. This deep genomic interrogation will allow the identification of rare, functionally disruptive variants that may play a role in disease progession and response to treatment.
collegamento
Keywords
versioni (1)
- 23/01/23 23/01/23 - Dr. Christian Niklas
Titolare del copyright
Elaine Mardis, PhD, The Genome Institute, Washington University School of Medicine, St. Louis, MO, USA
Caricato su
23 gennaio 2023
DOI
Per favore, per richiedere un accesso.
Licenza
Creative Commons BY 4.0
Commenti del modello :
Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.
Commenti del gruppo di articoli per :
Commenti dell'articolo per :
Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.
dbGaP phs000661 Germline Sequencing for Aggressive Prostate Carcinoma
Subject ID, consent group, and affection status of participants with prostate cancer and involved in the "Germline Sequencing for Aggressive Prostate Carcinoma" project.
- StudyEvent: SEV1
- Subject ID, consent group, and affection status of participants with prostate cancer and involved in the "Germline Sequencing for Aggressive Prostate Carcinoma" project.
- Subject ID, sample ID, and sample use variable of participants with prostate cancer and involved in the "Germline Sequencing for Aggressive Prostate Carcinoma" project.
- Subject ID and race of participants with prostate cancer and involved in the "Germline Sequencing for Aggressive Prostate Carcinoma" project.
- Sample ID, body site from which the tissue sample originated, tumor status of sample, and age of participants with prostate cancer and involved in the "Germline Sequencing for Aggressive Prostate Carcinoma" project.
Similar models
Subject ID, consent group, and affection status of participants with prostate cancer and involved in the "Germline Sequencing for Aggressive Prostate Carcinoma" project.
- StudyEvent: SEV1
- Subject ID, consent group, and affection status of participants with prostate cancer and involved in the "Germline Sequencing for Aggressive Prostate Carcinoma" project.
- Subject ID, sample ID, and sample use variable of participants with prostate cancer and involved in the "Germline Sequencing for Aggressive Prostate Carcinoma" project.
- Subject ID and race of participants with prostate cancer and involved in the "Germline Sequencing for Aggressive Prostate Carcinoma" project.
- Sample ID, body site from which the tissue sample originated, tumor status of sample, and age of participants with prostate cancer and involved in the "Germline Sequencing for Aggressive Prostate Carcinoma" project.
C4684638 (UMLS CUI [1,2])
C0441833 (UMLS CUI [1,2])